Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,479 across all filing types
Latest filing 2021-08-02 Transaction in Own Shar…
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2021
Transaction in Own Shares Classification · 1% confidence The document title explicitly states 'Coloplast – transactions in connection with share buy-back programme, week 30'. The content details the execution of a share buyback program, including daily transaction volumes, average purchase prices, and the accumulated total. This activity directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase programs.
2021-08-02 English
Coloplast A/S - Transactions in connection with share buy-back programme, week 29
Transaction in Own Shares Classification · 1% confidence The document is a detailed report of Coloplast's share buyback transactions for week 29 of 2021. It explicitly references 'aktietilbagekøbsprogram' (share buyback program) and provides granular transaction data (date, volume, price, venue) in compliance with EU Market Abuse Regulation (MAR). This falls directly under the category of 'Transaction in Own Shares'.
2021-07-26 English
Coloplast A/S - Transactions in connection with share buy-back programme, week 29
Transaction in Own Shares Classification · 1% confidence The document is a corporate announcement detailing specific transactions made by Coloplast under its share buyback program for the week of July 19-23, 2021. It lists the number of shares purchased, the average price, and the total transaction value, which is a standard disclosure for a company buying back its own shares. This falls directly under the 'Transaction in Own Shares' category.
2021-07-26 Danish
Coloplast A/S - Transactions in connection with share buy-back programme, week 29
Transaction in Own Shares Classification · 1% confidence The document is a weekly report from Coloplast A/S detailing transactions made under their share buyback program. It lists specific dates, the number of shares purchased, the average price, and the total transaction value for the week. This falls directly under the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2021-07-26 Danish
Coloplast A/S - Transactions in connection with share buy-back programme, week 29
Transaction in Own Shares Classification · 1% confidence The document is a detailed report of Coloplast's share buy-back program, listing specific transaction dates, volumes, prices, and venues for the week of 19-23 July 2021. This falls under the category of a company reporting on its own share repurchase activities, which is explicitly defined as 'Transaction in Own Shares' (POS).
2021-07-26 English
Transaction in Own Shares 2021
Transaction in Own Shares Classification · 1% confidence The document explicitly details 'Transactions in connection with share buy-back programme' for Coloplast A/S during a specific week (week 29, July 19-23, 2021). It lists the number of shares bought, the average price, and the total transaction value, along with the accumulated total under the program. This activity directly corresponds to the definition of a company repurchasing its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS). The document length is relatively short (3645 chars) and contains specific transaction data rather than being a general announcement of a report, confirming it is the primary disclosure of the transaction itself.
2021-07-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.